Alkermes (ALKS) Net Income Growth (1y) (2011 - 2025)
Alkermes (ALKS) Net Income Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 68.18% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -0.17% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -14.68% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -106.16% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2,405.06% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -14.93% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 62.34% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -286.15% |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 237.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6,347.91% |
| Dec 31, 2024 | 101.60% |
| Sep 30, 2024 | 99.05% |
| Jun 30, 2024 | 92.15% |
| Mar 31, 2024 | 92.88% |
| Dec 31, 2023 | -149.32% |
| Sep 30, 2023 | 31.54% |
| Jun 30, 2023 | -39.49% |
| Mar 31, 2023 | 17.01% |
| Dec 31, 2022 | -28.76% |
| Sep 30, 2022 | -120.69% |
| Jun 30, 2022 | -1,374.79% |
| Mar 31, 2022 | -60.15% |
| Dec 31, 2021 | 557.60% |
| Sep 30, 2021 | -21,532.84% |
| Jun 30, 2021 | 108.03% |
| Mar 31, 2021 | 42.00% |
| Dec 31, 2020 | -383.63% |
| Sep 30, 2020 | 99.75% |
| Jun 30, 2020 | 29.91% |